Sai Life Sciences Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences has submitted a routine compliance certificate to BSE and NSE under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018. The certificate was issued by KFin Technologies, the company's Registrar and Share Transfer Agent, dated January 2, 2026. It confirms that details of all securities dematerialized and rematerialized during the quarter ended December 31, 2025 have been furnished to the stock exchanges where the company's shares are listed. Separate confirmations were filed for both CDSL and NSDL depositories. This is a standard quarterly procedural filing required by SEBI.
This is a routine regulatory compliance filing with no material impact on the company's operations, financials, or share price. It simply confirms that share dematerialization and rematerialization activity during the quarter has been properly reported.